Browse by Changes
Summary of Changes – 1 August 2025
Page last updated: 1 August 2025
Previous versions of the Summary of Changes are available in PDF in the Publications Archive.
- Additions
- Deletions
- Alterations
- Supply Only
- Advance Notices
- Palliative Care
- Highly Specialised Drugs Program (Private Hospital)
- Highly Specialised Drugs Program (Public Hospital)
- Highly Specialised Drugs Program (Community Access)
- Repatriation Pharmaceutical Benefits
- Efficient Funding of Chemotherapy (Private Hospital)
- Efficient Funding of Chemotherapy (Public Hospital)
- Related Pharmaceutical Benefits for Public Hospital use
General Pharmaceutical Benefits
Additions
Addition – Item
| 14931W | DROSPIRENONE, drospirenone 4 mg tablet [24] (&) inert substance tablet [4], 3 x 28 (Slinda) |
| 14941J | DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 3 x 28 (Bella, Rosie, YANA) |
| 14954C | DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 28 (Bella, Rosie, YANA) |
| 14876Y | FOSLEVODOPA + FOSCARBIDOPA, foslevodopa 2.4 g/10 mL + foscarbidopa 120 mg/10 mL injection, 7 x 10 mL vials (Vyalev) |
| 14886L | FOSLEVODOPA + FOSCARBIDOPA, foslevodopa 2.4 g/10 mL + foscarbidopa 120 mg/10 mL injection, 7 x 10 mL vials (Vyalev) |
| 14887M | FOSLEVODOPA + FOSCARBIDOPA, foslevodopa 2.4 g/10 mL + foscarbidopa 120 mg/10 mL injection, 7 x 10 mL vials (Vyalev) |
| 14896B | FOSLEVODOPA + FOSCARBIDOPA, foslevodopa 2.4 g/10 mL + foscarbidopa 120 mg/10 mL injection, 7 x 10 mL vials (Vyalev) |
| 14877B | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma) |
| 14879D | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma) |
| 14890Q | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma) |
| 14891R | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma) |
| 14892T | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma) |
| 14898D | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma) |
| 14899E | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma) |
| 14908P | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma) |
| 14909Q | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma) |
| 14916C | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma) |
| 14933Y | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma) |
| 14944M | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe (Steqeyma) |
| 14878C | USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma) |
| 14893W | USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma) |
| 14897C | USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma) |
| 14907N | USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma) |
| 14917D | USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma) |
| 14918E | USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma) |
| 14926N | USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma) |
| 14934B | USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma) |
| 14935C | USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma) |
| 14943L | USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Steqeyma) |
Addition – Brand
| 2698B | ZYRON, NB – ABIRATERONE, abiraterone acetate 250 mg tablet, 120 |
| 11206T | ZYRON, NB – ABIRATERONE, abiraterone acetate 500 mg tablet, 60 |
| 9320M | Dabigatran Viatris, AF – DABIGATRAN, dabigatran etexilate 75 mg capsule, 60 |
| 13523R | Dabigatran Viatris, AF – DABIGATRAN, dabigatran etexilate 110 mg capsule, 60 |
| 2753X | Dabigatran Viatris, AF – DABIGATRAN, dabigatran etexilate 110 mg capsule, 60 |
| 9321N | Dabigatran Viatris, AF – DABIGATRAN, dabigatran etexilate 110 mg capsule, 60 |
| 13489Y | Dabigatran Viatris, AF – DABIGATRAN, dabigatran etexilate 150 mg capsule, 60 |
| 2769R | Dabigatran Viatris, AF – DABIGATRAN, dabigatran etexilate 150 mg capsule, 60 |
| 5457F | Jubbonti, SZ – DENOSUMAB, denosumab 60 mg/mL injection, 1 mL syringe |
| 10061M | Wyost, SZ – DENOSUMAB, denosumab 120 mg/1.7 mL injection, 1.7 mL vial |
| 5110Y | Wyost, SZ – DENOSUMAB, denosumab 120 mg/1.7 mL injection, 1.7 mL vial |
| 14711G | Isabelle, GQ – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 28 |
| 14711G | Rosalee, SZ – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 28 |
| 14711G | Yelena, XT – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 28 |
| 14725B | Isabelle, GQ – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 3 x 28 |
| 14725B | Rosalee, SZ – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 3 x 28 |
| 14725B | Yelena, XT – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 3 x 28 |
| 14349F | ESCITALOPRAM-WGR, WG – ESCITALOPRAM, escitalopram 10 mg tablet, 28 |
| 14519E | ESCITALOPRAM-WGR, WG – ESCITALOPRAM, escitalopram 10 mg tablet, 28 |
| 8700X | ESCITALOPRAM-WGR, WG – ESCITALOPRAM, escitalopram 10 mg tablet, 28 |
| 9432K | ESCITALOPRAM-WGR, WG – ESCITALOPRAM, escitalopram 10 mg tablet, 28 |
| 14415Q | ESCITALOPRAM-WGR, WG – ESCITALOPRAM, escitalopram 20 mg tablet, 28 |
| 14416R | ESCITALOPRAM-WGR, WG – ESCITALOPRAM, escitalopram 20 mg tablet, 28 |
| 8701Y | ESCITALOPRAM-WGR, WG – ESCITALOPRAM, escitalopram 20 mg tablet, 28 |
| 9433L | ESCITALOPRAM-WGR, WG – ESCITALOPRAM, escitalopram 20 mg tablet, 28 |
| 11621P | Isotretinoin Dr.Reddy's, RZ – ISOTRETINOIN, isotretinoin 20 mg capsule, 30 |
| 2592K | Isotretinoin Dr.Reddy's, RZ – ISOTRETINOIN, isotretinoin 20 mg capsule, 60 |
| 13463N | Relaban, NB – RIVAROXABAN, rivaroxaban 15 mg tablet, 28 |
| 2691P | Relaban, NB – RIVAROXABAN, rivaroxaban 15 mg tablet, 28 |
| 13462M | Relaban, NB – RIVAROXABAN, rivaroxaban 20 mg tablet, 28 |
| 2268J | Relaban, NB – RIVAROXABAN, rivaroxaban 20 mg tablet, 28 |
| 10551H | Rizatriptan-Au, DZ – RIZATRIPTAN, rizatriptan 10 mg orally disintegrating tablet, 2 |
| 13261Y | Steqeyma, EW – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe |
| 13273N | Steqeyma, EW – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe |
| 13789R | Steqeyma, EW – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe |
| 13805N | Steqeyma, EW – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe |
| 5469W | Varenicline Lupin, GQ – VARENICLINE, varenicline 1 mg tablet, 56 |
| 9129L | Varenicline Lupin, GQ – VARENICLINE, varenicline 1 mg tablet, 56 |
| 9128K | Varenicline Lupin, GQ – VARENICLINE, varenicline 500 microgram tablet [11] (&) varenicline 1 mg tablet [42], 53 |
Addition – Equivalence Indicator
| 5457F | Prolia, AN – DENOSUMAB, denosumab 60 mg/mL injection, 1 mL syringe |
| 10061M | Xgeva, AN – DENOSUMAB, denosumab 120 mg/1.7 mL injection, 1.7 mL vial |
| 5110Y | Xgeva, AN – DENOSUMAB, denosumab 120 mg/1.7 mL injection, 1.7 mL vial |
| 14711G | Yasmin, BN – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 28 |
| 14725B | Yasmin, BN – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 30 microgram tablet [21] (&) inert substance tablet [7], 3 x 28 |
| 14709E | Yaz, BN – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 3 x 28 |
| 14710F | Yaz, BN – DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 28 |
| 13261Y | Stelara, JC – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe |
| 13273N | Stelara, JC – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe |
| 13789R | Stelara, JC – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe |
| 13805N | Stelara, JC – USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe |
Addition – Note
| 5457F | DENOSUMAB, denosumab 60 mg/mL injection, 1 mL syringe (Jubbonti, Prolia) |
| 10061M | DENOSUMAB, denosumab 120 mg/1.7 mL injection, 1.7 mL vial (Wyost, Xgeva) |
| 5110Y | DENOSUMAB, denosumab 120 mg/1.7 mL injection, 1.7 mL vial (Wyost, Xgeva) |
| 14709E | DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 3 x 28 (Yaz) |
| 14710F | DROSPIRENONE + ETHINYLESTRADIOL, drospirenone 3 mg + ethinylestradiol 20 microgram tablet [24] (&) inert substance tablet [4], 28 (Yaz) |
Deletions
Deletion – Item
| 11329G | AFATINIB, afatinib 50 mg tablet, 28 (Giotrif) |
| 11342Y | AFATINIB, afatinib 50 mg tablet, 28 (Giotrif) |
| 14194C | MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL (RA-Morph (NZ)) |
| 14204N | MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL (RA-Morph (NZ)) |
| 8589C | QUINAPRIL + HYDROCHLOROTHIAZIDE, quinapril 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 (Accuretic 10/12.5mg) |
| 8590D | QUINAPRIL + HYDROCHLOROTHIAZIDE, quinapril 20 mg + hydrochlorothiazide 12.5 mg tablet, 30 (Accuretic 20/12.5mg) |
| 14636H | TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 (Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg/300 mg Tablets (Laurus Labs, USA)) |
| 10622C | YELLOW JACKET VENOM, yellow jacket venom 550 microgram injection [1 vial] (&) inert substance diluent [9 mL vial], 1 pack (Hymenoptera Yellow Jacket Venom) |
Deletion – Brand
| 1052J | Aciclovir APOTEX, TY – ACICLOVIR, aciclovir 800 mg tablet, 35 |
| 8878G | Durogesic 12, JC – FENTANYL, fentanyl 12 microgram/hour patch, 5 |
| 8891Y | Durogesic 25, JC – FENTANYL, fentanyl 25 microgram/hour patch, 5 |
| 8892B | Durogesic 50, JC – FENTANYL, fentanyl 50 microgram/hour patch, 5 |
| 8893C | Durogesic 75, JC – FENTANYL, fentanyl 75 microgram/hour patch, 5 |
| 8894D | Durogesic 100, JC – FENTANYL, fentanyl 100 microgram/hour patch, 5 |
| 8729K | Granisetron-AFT, AE – GRANISETRON, granisetron 3 mg/3 mL injection, 3 mL ampoule |
| 8730L | Granisetron-AFT, AE – GRANISETRON, granisetron 3 mg/3 mL injection, 3 mL ampoule |
| 14526M | Montelukast Mylan, AF – MONTELUKAST, montelukast 4 mg chewable tablet, 28 |
| 8627C | Montelukast Mylan, AF – MONTELUKAST, montelukast 4 mg chewable tablet, 28 |
| 10005N | Olmekar HCT 20/5/12.5, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 13481M | Olmekar HCT 20/5/12.5, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 13512E | Olmekar HCT 40/5/25, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 25 mg tablet, 30 |
| 13513F | Olmekar HCT 40/5/12.5, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 2864R | Olmekar HCT 40/5/25, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 25 mg tablet, 30 |
| 2880N | Olmekar HCT 40/5/12.5, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 13482N | Olmekar HCT 40/10/12.5, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 14002Y | Olmekar HCT 40/10/25, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 25 mg tablet, 30 |
| 2836G | Olmekar HCT 40/10/12.5, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 2953K | Olmekar HCT 40/10/25, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 25 mg tablet, 30 |
| 14367E | Noumed Paroxetine, VO – PAROXETINE, paroxetine 20 mg tablet, 30 |
| 2242B | Noumed Paroxetine, VO – PAROXETINE, paroxetine 20 mg tablet, 30 |
Deletion – Equivalence Indicator
| 8729K | Kytril, IX – GRANISETRON, granisetron 3 mg/3 mL injection, 3 mL ampoule |
| 8730L | Kytril, IX – GRANISETRON, granisetron 3 mg/3 mL injection, 3 mL ampoule |
Deletion – Note
| 14275H | ADALIMUMAB, adalimumab 20 mg/0.2 mL injection, 2 x 0.2 mL syringes (Humira) |
| 14747E | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 0.4 mL syringe (Amgevita) |
| 14750H | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 14221L | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Humira, Hyrimoz, Yuflyma) |
| 14591Y | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (Hadlima, Humira, Hyrimoz, Yuflyma) |
| 14251C | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Abrilada, Amgevita, Hadlima, Hyrimoz) |
| 14261N | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz) |
| 14297L | CABOZANTINIB, cabozantinib 20 mg tablet, 30 (Cabometyx) |
| 14254F | CABOZANTINIB, cabozantinib 40 mg tablet, 30 (Cabometyx) |
| 14237H | CABOZANTINIB, cabozantinib 60 mg tablet, 30 (Cabometyx) |
| 11276L | TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 (CIPLA TENOFOVIR + EMTRICITABINE 300/200, TENOFOVIR/EMTRICITABINE 300/200 APX, TENOFOVIR/EMTRICITABINE 300/200 ARX) |
| 11296M | TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil maleate 300 mg + emtricitabine 200 mg tablet, 30 (Tenofovir Disoproxil Emtricitabine Viatris 300/200) |
| 12542D | TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil succinate 301 mg + emtricitabine 200 mg tablet, 30 (Tenofovir/Emtricitabine Sandoz 301/200) |
| 12662K | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara) |
| 12664M | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara) |
| 13789R | USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Stelara, Steqeyma) |
Deletion – Restriction
| 14275H | ADALIMUMAB, adalimumab 20 mg/0.2 mL injection, 2 x 0.2 mL syringes (Humira) |
| 14747E | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 0.4 mL syringe (Amgevita) |
| 14750H | ADALIMUMAB, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Abrilada) |
| 14221L | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (Hadlima, Humira, Hyrimoz, Yuflyma) |
| 14591Y | ADALIMUMAB, adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (Hadlima, Humira, Hyrimoz, Yuflyma) |
| 14251C | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Abrilada, Amgevita, Hadlima, Hyrimoz) |
| 14261N | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (Abrilada, Amgevita, Hadlima, Hyrimoz) |
| 14297L | CABOZANTINIB, cabozantinib 20 mg tablet, 30 (Cabometyx) |
| 14254F | CABOZANTINIB, cabozantinib 40 mg tablet, 30 (Cabometyx) |
| 14237H | CABOZANTINIB, cabozantinib 60 mg tablet, 30 (Cabometyx) |
Alterations
Alteration – Item Description
| From | |
| 14638K | DAPAGLIFLOZIN + SITAGLIPTIN, dapagliflozin 10 mg + sitagliptin 100 mg tablet, 28 (Sidapvia 10/100) |
| To | |
| 14638K | DAPAGLIFLOZIN + SITAGLIPTIN, Dapagliflozin 10 mg + sitagliptin 100 mg tablet, 28 (Sidapvia 10/100) |
| From | |
| 14645T | DAPAGLIFLOZIN + SITAGLIPTIN, dapagliflozin 10 mg + sitagliptin 100 mg tablet, 28 (Sidapvia 10/100) |
| To | |
| 14645T | DAPAGLIFLOZIN + SITAGLIPTIN, Dapagliflozin 10 mg + sitagliptin 100 mg tablet, 28 (Sidapvia 10/100) |
| From | |
| 14792M | EPCORITAMAB, epcoritamab 4 mg/0.8 mL injection, 0.8 mL vial (Epkinly) |
| To | |
| 14792M | EPCORITAMAB, Epcoritamab 4 mg/0.8 mL injection, 0.8 mL vial (Epkinly) |
| From | |
| 14809K | EPCORITAMAB, epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly) |
| To | |
| 14809K | EPCORITAMAB, Epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly) |
| From | |
| 14819Y | EPCORITAMAB, epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly) |
| To | |
| 14819Y | EPCORITAMAB, Epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly) |
| From | |
| 14617H | ICOSAPENT ETHYL, icosapent ethyl 998 mg capsule, 120 (Vazkepa) |
| To | |
| 14617H | ICOSAPENT ETHYL, Icosapent ethyl 998 mg capsule, 120 (Vazkepa) |
| From | |
| 14743Y | MOMELOTINIB, momelotinib 100 mg tablet, 30 (Omjjara) |
| To | |
| 14743Y | MOMELOTINIB, Momelotinib 100 mg tablet, 30 (Omjjara) |
| From | |
| 14769H | MOMELOTINIB, momelotinib 100 mg tablet, 30 (Omjjara) |
| To | |
| 14769H | MOMELOTINIB, Momelotinib 100 mg tablet, 30 (Omjjara) |
| From | |
| 14744B | MOMELOTINIB, momelotinib 150 mg tablet, 30 (Omjjara) |
| To | |
| 14744B | MOMELOTINIB, Momelotinib 150 mg tablet, 30 (Omjjara) |
| From | |
| 14762Y | MOMELOTINIB, momelotinib 150 mg tablet, 30 (Omjjara) |
| To | |
| 14762Y | MOMELOTINIB, Momelotinib 150 mg tablet, 30 (Omjjara) |
| From | |
| 14763B | MOMELOTINIB, momelotinib 200 mg tablet, 30 (Omjjara) |
| To | |
| 14763B | MOMELOTINIB, Momelotinib 200 mg tablet, 30 (Omjjara) |
| From | |
| 14770J | MOMELOTINIB, momelotinib 200 mg tablet, 30 (Omjjara) |
| To | |
| 14770J | MOMELOTINIB, Momelotinib 200 mg tablet, 30 (Omjjara) |
Alteration – Brand Name
| From | |
| 14408H | Chemists’ Own Constipation Relief with electrolytes, OW – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets |
| To | |
| 14408H | Chemists' Own Constipation Relief with electrolytes, OW – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets |
| From | |
| 8612G | Chemists’ Own Constipation Relief with electrolytes, OW – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets |
| To | |
| 8612G | Chemists' Own Constipation Relief with electrolytes, OW – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets |
Alteration – Note
| 14077X | MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 20 mL (Morphini HCl Streuli) |
| 14083F | MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 20 mL (Morphini HCl Streuli) |
| 2124T | MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL (Ordine 10) |
| 5239R | MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL (Ordine 10) |
| 10767Q | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara) |
| 10774C | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara) |
| 11178H | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara) |
| 12669T | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara) |
| 9304Q | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara) |
| 9305R | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara) |
| 13261Y | USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Stelara, Steqeyma) |
| 13273N | USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Stelara, Steqeyma) |
| 13805N | USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Stelara, Steqeyma) |
Alteration – Restriction
| 14116Y | ABEMACICLIB, abemaciclib 50 mg tablet, 56 (Verzenio) |
| 14105J | ABEMACICLIB, abemaciclib 100 mg tablet, 56 (Verzenio) |
| 14134X | ABEMACICLIB, abemaciclib 150 mg tablet, 56 (Verzenio) |
| 10767Q | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara) |
| 10774C | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara) |
| 11178H | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara) |
| 12662K | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara) |
| 12664M | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara) |
| 12669T | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara) |
| 9304Q | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara) |
| 9305R | USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara) |
| 13261Y | USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Stelara, Steqeyma) |
| 13273N | USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Stelara, Steqeyma) |
| 13789R | USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Stelara, Steqeyma) |
| 13805N | USTEKINUMAB, ustekinumab 90 mg/mL injection, 1 mL syringe (Stelara, Steqeyma) |
Alteration – Number of Repeats
| From | To | ||
| 14573B | MIGALASTAT, migalastat 123 mg capsule, 14 (Galafold) | 5 | 6 |
Supply Only
Supply Only – Period Commencing
| 9438R | AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT LYSINE AND LOW IN TRYPTOPHAN, amino acid formula with vitamins and minerals without lysine and low in tryptophan powder for oral liquid, 30 x 24 g sachets (GA gel) |
| 14425F | BETAXOLOL, betaxolol 0.5% eye drops, 5 mL (Betoptic) |
| 2825Q | BETAXOLOL, betaxolol 0.5% eye drops, 5 mL (Betoptic) |
| 5544T | BETAXOLOL, betaxolol 0.5% eye drops, 5 mL (Betoptic) |
| 8527T | TENECTEPLASE, tenecteplase 50 mg injection [1 vial] (&) inert substance diluent [10 mL syringe], 1 pack (Metalyse) |
Supply Only – Period Ending
| 11287C | GLYCOMACROPEPTIDE AND ESSENTIAL AMINO ACIDS WITH VITAMINS AND MINERALS, glycomacropeptide and essential amino acids with vitamins and minerals containing 10 g of protein equivalent powder for oral liquid, 60 x 16 g sachets (PKU Build 10) |
| 2676W | PROTEIN HYDROLYSATE FORMULA WITH MEDIUM CHAIN TRIGLYCERIDES, protein hydrolysate formula with medium chain triglycerides powder for oral liquid, 400 g (Alfaré) |
Advance Notices
1 September 2025
Deletion – Brand
| 14726C | Acarbose 50 mg tablets (Morningside, UK), DZ – ACARBOSE, acarbose 50 mg tablet, 90 |
| 14735M | Acarbose 50 mg tablets (Morningside, UK), DZ – ACARBOSE, acarbose 50 mg tablet, 90 |
| 1555W | Aciclovir APOTEX, TY – ACICLOVIR, aciclovir 200 mg tablet, 50 |
| 13575L | Allopurinol APOTEX, GX – ALLOPURINOL, allopurinol 300 mg tablet, 60 |
| 2604C | Allopurinol APOTEX, GX – ALLOPURINOL, allopurinol 300 mg tablet, 60 |
| 3417W | HCU Anamix junior LQ, SB – AMINO ACID FORMULA WITH FAT, CARBOHYDRATE, VITAMINS, MINERALS AND TRACE ELEMENTS WITHOUT METHIONINE AND SUPPLEMENTED WITH DOCOSAHEXAENOIC ACID, amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without methionine and supplemented with docosahexaenoic acid oral liquid, 36 x 125 mL bottles |
| 9330C | TYR Anamix junior LQ, SB – AMINO ACID FORMULA WITH FAT, CARBOHYDRATE, VITAMINS, MINERALS AND TRACE ELEMENTS WITHOUT PHENYLALANINE AND TYROSINE, AND SUPPLEMENTED WITH DOCOSAHEXAENOIC ACID, amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine, and supplemented with docosahexaenoic acid oral liquid, 36 x 125 mL bottles |
| 9499Y | MSUD Anamix Junior LQ, SB – AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT VALINE, LEUCINE AND ISOLEUCINE WITH FAT, CARBOHYDRATE AND TRACE ELEMENTS AND SUPPLEMENTED WITH DOCOSAHEXAENOIC ACID, amino acid formula with vitamins and minerals without valine, leucine and isoleucine with fat, carbohydrate and trace elements and supplemented with docosahexaenoic acid oral liquid, 36 x 125 mL bottles |
| 8596K | Amipride 400, RW – AMISULPRIDE, amisulpride 400 mg tablet, 60 |
| 13532F | Blooms the Chemist Amlodipine, IB – AMLODIPINE, amlodipine 5 mg tablet, 30 |
| 13562T | Blooms the Chemist Amlodipine, IB – AMLODIPINE, amlodipine 10 mg tablet, 30 |
| 2751T | Blooms the Chemist Amlodipine, IB – AMLODIPINE, amlodipine 5 mg tablet, 30 |
| 2752W | Blooms the Chemist Amlodipine, IB – AMLODIPINE, amlodipine 10 mg tablet, 30 |
| 11941L | Amoxycillin/Clavulanic Acid 500/125 APOTEX, TY – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 500 mg + clavulanic acid 125 mg tablet, 10 |
| 1891M | Amoxycillin/Clavulanic Acid 500/125 APOTEX, TY – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 500 mg + clavulanic acid 125 mg tablet, 10 |
| 5008N | Amoxycillin/Clavulanic Acid 500/125 APOTEX, TY – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 500 mg + clavulanic acid 125 mg tablet, 10 |
| 5296R | Riamet 20mg/120mg Dispersible, NV – ARTEMETHER + LUMEFANTRINE, artemether 20 mg + lumefantrine 120 mg dispersible tablet, 18 |
| 13391T | Blooms the Chemist Candesartan HCTZ 16/12.5, IB – CANDESARTAN + HYDROCHLOROTHIAZIDE, candesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 8504N | Blooms the Chemist Candesartan HCTZ 16/12.5, IB – CANDESARTAN + HYDROCHLOROTHIAZIDE, candesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 8439E | Blooms the Chemist Celecoxib, IB – CELECOXIB, celecoxib 100 mg capsule, 60 |
| 8439E | Celecoxib APOTEX, TY – CELECOXIB, celecoxib 100 mg capsule, 60 |
| 8440F | Blooms the Chemist Celecoxib, IB – CELECOXIB, celecoxib 200 mg capsule, 30 |
| 8440F | Celecoxib APOTEX, TY – CELECOXIB, celecoxib 200 mg capsule, 30 |
| 5265D | Denpax, AF – FENTANYL, fentanyl 12 microgram/hour patch, 5 |
| 5277R | Denpax, AF – FENTANYL, fentanyl 25 microgram/hour patch, 5 |
| 5278T | Denpax, AF – FENTANYL, fentanyl 50 microgram/hour patch, 5 |
| 5279W | Denpax, AF – FENTANYL, fentanyl 75 microgram/hour patch, 5 |
| 5280X | Denpax, AF – FENTANYL, fentanyl 100 microgram/hour patch, 5 |
| 5437E | Fenpatch 12, RW – FENTANYL, fentanyl 12 microgram/hour patch, 5 |
| 5438F | Fenpatch 25, RW – FENTANYL, fentanyl 25 microgram/hour patch, 5 |
| 5439G | Fenpatch 50, RW – FENTANYL, fentanyl 50 microgram/hour patch, 5 |
| 5440H | Fenpatch 75, RW – FENTANYL, fentanyl 75 microgram/hour patch, 5 |
| 5441J | Fenpatch 100, RW – FENTANYL, fentanyl 100 microgram/hour patch, 5 |
| 10915L | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
| 10918P | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
| 10920R | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
| 10924Y | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
| 10940T | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
| 10941W | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
| 10942X | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
| 11757T | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
| 11770L | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
| 11776T | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
| 11777W | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
| 11782D | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
| 11783E | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
| 11875B | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
| 12709X | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
| 12710Y | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
| 12722N | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
| 12759M | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
| 13564X | Blooms the Chemist Irbesartan, IB – IRBESARTAN, irbesartan 300 mg tablet, 30 |
| 8248D | Blooms the Chemist Irbesartan, IB – IRBESARTAN, irbesartan 300 mg tablet, 30 |
| 13446Q | Blooms the Chemist Irbesartan HCTZ 300/25, IB – IRBESARTAN + HYDROCHLOROTHIAZIDE, irbesartan 300 mg + hydrochlorothiazide 25 mg tablet, 30 |
| 13545X | Blooms the Chemist Irbesartan HCTZ 300/12.5, IB – IRBESARTAN + HYDROCHLOROTHIAZIDE, irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 13572H | Blooms the Chemist Irbesartan HCTZ 150/12.5, IB – IRBESARTAN + HYDROCHLOROTHIAZIDE, irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 2136K | Blooms the Chemist Irbesartan HCTZ 300/25, IB – IRBESARTAN + HYDROCHLOROTHIAZIDE, irbesartan 300 mg + hydrochlorothiazide 25 mg tablet, 30 |
| 8404H | Blooms the Chemist Irbesartan HCTZ 150/12.5, IB – IRBESARTAN + HYDROCHLOROTHIAZIDE, irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 8405J | Blooms the Chemist Irbesartan HCTZ 300/12.5, IB – IRBESARTAN + HYDROCHLOROTHIAZIDE, irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 14553Y | Montelukast Mylan, AF – MONTELUKAST, montelukast 5 mg chewable tablet, 28 |
| 8628D | Montelukast Mylan, AF – MONTELUKAST, montelukast 5 mg chewable tablet, 28 |
| 13747M | Morphine Sulfate (Hikma) 10 mg/5 mL (2 mg/mL), DZ – MORPHINE, morphine sulfate 2 mg/mL oral solution, 100 mL |
| 13749P | Morphine Sulfate (Hikma) 10 mg/5 mL (2 mg/mL), DZ – MORPHINE, morphine sulfate 2 mg/mL oral solution, 500 mL |
| 13753W | Morphine Sulfate (Hikma) 10 mg/5 mL (2 mg/mL), DZ – MORPHINE, morphine sulfate 2 mg/mL oral solution, 100 mL |
| 13760F | Morphine Sulfate (Hikma) 10 mg/5 mL (2 mg/mL), DZ – MORPHINE, morphine sulfate 2 mg/mL oral solution, 500 mL |
| 14077X | Morphini HCl Streuli, DZ – MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 20 mL |
| 14083F | Morphini HCl Streuli, DZ – MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 20 mL |
| 1653B | MORPHINE MR APOTEX, TX – MORPHINE, morphine sulfate pentahydrate 10 mg modified release tablet, 28 |
| 1654C | MORPHINE MR APOTEX, TX – MORPHINE, morphine sulfate pentahydrate 30 mg modified release tablet, 28 |
| 1655D | MORPHINE MR APOTEX, TX – MORPHINE, morphine sulfate pentahydrate 60 mg modified release tablet, 28 |
| 1656E | MORPHINE MR APOTEX, TX – MORPHINE, morphine sulfate pentahydrate 100 mg modified release tablet, 28 |
| 14000W | MycoCept, RF – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
| 8650G | MycoCept, RF – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
| 13449W | Olmesartan/Amlodipine 20/5 APOTEX, TX – OLMESARTAN + AMLODIPINE, olmesartan medoxomil 20 mg + amlodipine 5 mg tablet, 30 |
| 5292M | Olmesartan/Amlodipine 20/5 APOTEX, TX – OLMESARTAN + AMLODIPINE, olmesartan medoxomil 20 mg + amlodipine 5 mg tablet, 30 |
| 11682W | Pemzo, RW – OMEPRAZOLE, omeprazole 20 mg enteric capsule, 30 |
| 12281J | Pemzo, RW – OMEPRAZOLE, omeprazole 20 mg enteric capsule, 30 |
| 1326T | Pemzo, RW – OMEPRAZOLE, omeprazole 20 mg enteric capsule, 30 |
| 1327W | Pemzo, RW – OMEPRAZOLE, omeprazole 20 mg enteric capsule, 30 |
| 14464G | Pemzo, RW – OMEPRAZOLE, omeprazole 20 mg enteric capsule, 30 |
| 14465H | Pemzo, RW – OMEPRAZOLE, omeprazole 20 mg enteric capsule, 30 |
| 14559G | Pemzo, RW – OMEPRAZOLE, omeprazole 20 mg enteric capsule, 30 |
| 14706B | Pemzo, RW – OMEPRAZOLE, omeprazole 20 mg enteric capsule, 30 |
| 1594X | APO-Ondansetron, TX – ONDANSETRON, ondansetron 4 mg tablet, 10 |
| 1595Y | APO-Ondansetron, TX – ONDANSETRON, ondansetron 8 mg tablet, 10 |
| 8224W | APO-Ondansetron, TX – ONDANSETRON, ondansetron 4 mg tablet, 4 |
| 8225X | APO-Ondansetron, TX – ONDANSETRON, ondansetron 8 mg tablet, 4 |
| 14367E | APO-Paroxetine, TX – PAROXETINE, paroxetine 20 mg tablet, 30 |
| 2242B | APO-Paroxetine, TX – PAROXETINE, paroxetine 20 mg tablet, 30 |
| 13371R | Blooms the Chemist Perindopril, IB – PERINDOPRIL, perindopril erbumine 4 mg tablet, 30 |
| 13372T | Blooms the Chemist Perindopril, IB – PERINDOPRIL, perindopril erbumine 8 mg tablet, 30 |
| 13404L | Blooms the Chemist Perindopril, IB – PERINDOPRIL, perindopril erbumine 2 mg tablet, 30 |
| 3050M | Blooms the Chemist Perindopril, IB – PERINDOPRIL, perindopril erbumine 2 mg tablet, 30 |
| 3051N | Blooms the Chemist Perindopril, IB – PERINDOPRIL, perindopril erbumine 4 mg tablet, 30 |
| 8704D | Blooms the Chemist Perindopril, IB – PERINDOPRIL, perindopril erbumine 8 mg tablet, 30 |
| 13898L | APOTEX-Pioglitazone, TX – PIOGLITAZONE, pioglitazone 15 mg tablet, 28 |
| 8694N | APOTEX-Pioglitazone, TX – PIOGLITAZONE, pioglitazone 15 mg tablet, 28 |
| 14324X | APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 375 microgram modified release tablet, 30 |
| 14325Y | APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 4.5 mg modified release tablet, 30 |
| 14360T | APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 1.5 mg modified release tablet, 30 |
| 14459B | APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 750 microgram modified release tablet, 30 |
| 14460C | APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 3 mg modified release tablet, 30 |
| 14461D | APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 3.75 mg modified release tablet, 30 |
| 14556D | APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 2.25 mg modified release tablet, 30 |
| 3418X | APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 375 microgram modified release tablet, 30 |
| 3419Y | APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 750 microgram modified release tablet, 30 |
| 3420B | APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 1.5 mg modified release tablet, 30 |
| 3421C | APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 3 mg modified release tablet, 30 |
| 3422D | APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 4.5 mg modified release tablet, 30 |
| 5143Q | APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 2.25 mg modified release tablet, 30 |
| 5145T | APO-Pramipexole ER, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 3.75 mg modified release tablet, 30 |
| 2348N | Blooms The Chemist Pregabalin, IB – PREGABALIN, pregabalin 25 mg capsule, 56 |
| 2355Y | Blooms The Chemist Pregabalin, IB – PREGABALIN, pregabalin 150 mg capsule, 56 |
| 2363J | Blooms The Chemist Pregabalin, IB – PREGABALIN, pregabalin 300 mg capsule, 56 |
| 13406N | Rosuvastatin APOTEX, GX – ROSUVASTATIN, rosuvastatin 5 mg tablet, 30 |
| 2606E | Rosuvastatin APOTEX, GX – ROSUVASTATIN, rosuvastatin 5 mg tablet, 30 |
| 11993F | APO-Roxithromycin, TX – ROXITHROMYCIN, roxithromycin 300 mg tablet, 5 |
| 12001P | APO-Roxithromycin, TX – ROXITHROMYCIN, roxithromycin 150 mg tablet, 10 |
| 1760P | APO-Roxithromycin, TX – ROXITHROMYCIN, roxithromycin 150 mg tablet, 10 |
| 5260W | APO-Roxithromycin, TX – ROXITHROMYCIN, roxithromycin 150 mg tablet, 10 |
| 5261X | APO-Roxithromycin, TX – ROXITHROMYCIN, roxithromycin 300 mg tablet, 5 |
| 8016X | APO-Roxithromycin, TX – ROXITHROMYCIN, roxithromycin 300 mg tablet, 5 |
| 5480K | Valaciclovir APOTEX, GX – VALACICLOVIR, valaciclovir 500 mg tablet, 30 |
| 8064K | Valaciclovir APOTEX, GX – VALACICLOVIR, valaciclovir 500 mg tablet, 42 |
| 8133C | Valaciclovir APOTEX, GX – VALACICLOVIR, valaciclovir 500 mg tablet, 10 |
| 8134D | Valaciclovir APOTEX, GX – VALACICLOVIR, valaciclovir 500 mg tablet, 30 |
1 October 2025
Deletion – Brand
| 13419G | NOUMED BISOPROLOL, VO – BISOPROLOL, bisoprolol fumarate 2.5 mg tablet, 28 |
| 13443M | NOUMED BISOPROLOL, VO – BISOPROLOL, bisoprolol fumarate 5 mg tablet, 28 |
| 13444N | NOUMED BISOPROLOL, VO – BISOPROLOL, bisoprolol fumarate 10 mg tablet, 28 |
| 8604W | NOUMED BISOPROLOL, VO – BISOPROLOL, bisoprolol fumarate 2.5 mg tablet, 28 |
| 8605X | NOUMED BISOPROLOL, VO – BISOPROLOL, bisoprolol fumarate 5 mg tablet, 28 |
| 8606Y | NOUMED BISOPROLOL, VO – BISOPROLOL, bisoprolol fumarate 10 mg tablet, 28 |
| 1475P | Fluconazole APOTEX, GX – FLUCONAZOLE, fluconazole 200 mg capsule, 28 |
| 14526M | Montelukast APOTEX, GX – MONTELUKAST, montelukast 4 mg chewable tablet, 28 |
| 14553Y | Montelukast APOTEX, GX – MONTELUKAST, montelukast 5 mg chewable tablet, 28 |
| 8627C | Montelukast APOTEX, GX – MONTELUKAST, montelukast 4 mg chewable tablet, 28 |
| 8628D | Montelukast APOTEX, GX – MONTELUKAST, montelukast 5 mg chewable tablet, 28 |
| 8185T | Olanzapine APOTEX, GX – OLANZAPINE, olanzapine 5 mg tablet, 28 |
| 13964Y | Olmesartan/Amlodipine 40/5 APOTEX, TX – OLMESARTAN + AMLODIPINE, olmesartan medoxomil 40 mg + amlodipine 5 mg tablet, 30 |
| 5293N | Olmesartan/Amlodipine 40/5 APOTEX, TX – OLMESARTAN + AMLODIPINE, olmesartan medoxomil 40 mg + amlodipine 5 mg tablet, 30 |
| 5470X | Ondansetron Mylan ODT, AF – ONDANSETRON, ondansetron 4 mg orally disintegrating tablet, 4 |
| 5472B | Ondansetron Mylan ODT, AF – ONDANSETRON, ondansetron 4 mg orally disintegrating tablet, 10 |
1 November 2025
Deletion – Brand
| 8559L | Gabapentin APOTEX, TY – GABAPENTIN, gabapentin 600 mg tablet, 100 |
| 10916M | Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30 |
| 10917N | Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30 |
| 10921T | Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30 |
| 10925B | Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30 |
| 10933K | Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30 |
| 10935M | Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30 |
| 10939R | Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30 |
| 11756R | Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30 |
| 11763D | Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30 |
| 11764E | Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30 |
| 11771M | Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30 |
| 11772N | Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30 |
| 11779Y | Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30 |
| 11870R | Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30 |
| 12681K | Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30 |
| 12711B | Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30 |
| 12723P | Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30 |
| 12754G | Imatinib-APOTEX, TX – IMATINIB, imatinib 400 mg capsule, 30 |
| 14501F | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 20 mg enteric tablet, 30 |
| 8399C | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 20 mg enteric tablet, 30 |
| 13921Q | APOTEX-Pioglitazone, TX – PIOGLITAZONE, pioglitazone 30 mg tablet, 28 |
| 8695P | APOTEX-Pioglitazone, TX – PIOGLITAZONE, pioglitazone 30 mg tablet, 28 |
Palliative Care
Deletions
Deletion – Item
| 14187Q | MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL (RA-Morph (NZ)) |
Deletion – Brand
| 12541C | Durogesic 12, JC – FENTANYL, fentanyl 12 microgram/hour patch, 5 |
| 12504D | Durogesic 25, JC – FENTANYL, fentanyl 25 microgram/hour patch, 5 |
| 12477Q | Durogesic 50, JC – FENTANYL, fentanyl 50 microgram/hour patch, 5 |
| 12474M | Durogesic 75, JC – FENTANYL, fentanyl 75 microgram/hour patch, 5 |
| 12509J | Durogesic 100, JC – FENTANYL, fentanyl 100 microgram/hour patch, 5 |
Alterations
Alteration – Brand Name
| From | |
| 5389P | Chemists’ Own Constipation Relief with electrolytes, OW – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets |
| To | |
| 5389P | Chemists' Own Constipation Relief with electrolytes, OW – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets |
Alteration – Note
| 12472K | MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL (Ordine 10) |
| 14081D | MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 20 mL (Morphini HCl Streuli) |
Advance Notices
1 September 2025
Deletion – Brand
| 12480W | Fenpatch 100, RW – FENTANYL, fentanyl 100 microgram/hour patch, 5 |
| 12491K | Denpax, AF – FENTANYL, fentanyl 12 microgram/hour patch, 5 |
| 12513N | Fenpatch 50, RW – FENTANYL, fentanyl 50 microgram/hour patch, 5 |
| 12516R | Denpax, AF – FENTANYL, fentanyl 25 microgram/hour patch, 5 |
| 12517T | Fenpatch 75, RW – FENTANYL, fentanyl 75 microgram/hour patch, 5 |
| 12521B | Fenpatch 25, RW – FENTANYL, fentanyl 25 microgram/hour patch, 5 |
| 12526G | Denpax, AF – FENTANYL, fentanyl 75 microgram/hour patch, 5 |
| 12530L | Fenpatch 12, RW – FENTANYL, fentanyl 12 microgram/hour patch, 5 |
| 12533P | Denpax, AF – FENTANYL, fentanyl 100 microgram/hour patch, 5 |
| 12546H | Denpax, AF – FENTANYL, fentanyl 50 microgram/hour patch, 5 |
| 12483B | MORPHINE MR APOTEX, TX – MORPHINE, morphine sulfate pentahydrate 100 mg modified release tablet, 28 |
| 12500X | MORPHINE MR APOTEX, TX – MORPHINE, morphine sulfate pentahydrate 30 mg modified release tablet, 28 |
| 12544F | MORPHINE MR APOTEX, TX – MORPHINE, morphine sulfate pentahydrate 60 mg modified release tablet, 28 |
| 12547J | MORPHINE MR APOTEX, TX – MORPHINE, morphine sulfate pentahydrate 10 mg modified release tablet, 28 |
| 13743H | Morphine Sulfate (Hikma) 10 mg/5 mL (2 mg/mL), DZ – MORPHINE, morphine sulfate 2 mg/mL oral solution, 100 mL |
| 13748N | Morphine Sulfate (Hikma) 10 mg/5 mL (2 mg/mL), DZ – MORPHINE, morphine sulfate 2 mg/mL oral solution, 500 mL |
| 14081D | Morphini HCl Streuli, DZ – MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 20 mL |
Highly Specialised Drugs Program (Private Hospital)
Additions
Addition – Item
| 14900F | EFLORNITHINE, eflornithine 192 mg tablet, 100 (Ifinwil) |
| 14910R | EFLORNITHINE, eflornithine 192 mg tablet, 100 (Ifinwil) |
| 14888N | FOSLEVODOPA + FOSCARBIDOPA, foslevodopa 2.4 g/10 mL + foscarbidopa 120 mg/10 mL injection, 7 x 10 mL vials (Vyalev) |
| 14915B | FOSLEVODOPA + FOSCARBIDOPA, foslevodopa 2.4 g/10 mL + foscarbidopa 120 mg/10 mL injection, 7 x 10 mL vials (Vyalev) |
| 14882G | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo) |
| 14904K | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair) |
| 14919F | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo) |
| 14921H | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair) |
| 14939G | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair) |
| 14883H | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair) |
| 14903J | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair) |
| 14911T | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 14923K | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair) |
| 14927P | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 14928Q | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair) |
| 14938F | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair) |
| 14912W | OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair) |
| 14930T | OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair) |
| 14940H | OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair) |
| 14951X | OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair) |
| 14953B | OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair) |
Note - Erratum
The listing of ivacaftor item codes 14902H and 14936D is no longer proceeding for
1 August 2025.
Addition – Brand
| 10110D | Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 10956P | Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 11826K | Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 11840E | Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 11952C | Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 11958J | Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 10122R | Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 10968G | Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11163M | Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11175E | Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11825J | Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11864K | Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11932B | Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11953D | Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11164N | Steqeyma, EW – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial |
| 13255P | Steqeyma, EW – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial |
| 13804M | Steqeyma, EW – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial |
Addition – Equivalence Indicator
| 10110D | Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 10956P | Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 11826K | Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 11840E | Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 11952C | Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 11958J | Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 11164N | Stelara, JC – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial |
| 13255P | Stelara, JC – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial |
| 13804M | Stelara, JC – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial |
Addition – Note
| 10110D | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair) |
| 10956P | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair) |
| 11826K | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair) |
| 11840E | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair) |
| 10122R | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11825J | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11864K | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
Addition – Caution
| 10956P | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair) |
| 11952C | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair) |
| 11958J | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair) |
| 10968G | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11932B | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11953D | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
Deletions
Deletion – Brand
| 10122R | Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 10968G | Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11163M | Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11175E | Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11825J | Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11864K | Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11932B | Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11953D | Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
Alterations
Alteration – Item Description
| From | |
| 14828K | MACITENTAN + TADALAFIL, macitentan 10 mg + tadalafil 40 mg tablet, 30 (Opsynvi) |
| To | |
| 14828K | MACITENTAN + TADALAFIL, Macitentan 10 mg + tadalafil 40 mg tablet, 30 (Opsynvi) |
| From | |
| 14829L | VUTRISIRAN, vutrisiran 25 mg/0.5 mL injection, 0.5 mL syringe (Amvuttra) |
| To | |
| 14829L | VUTRISIRAN, Vutrisiran 25 mg/0.5 mL injection, 0.5 mL syringe (Amvuttra) |
Alteration – Note
| 11163M | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11175E | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11953D | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11164N | USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma) |
| 13255P | USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma) |
| 13804M | USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma) |
Alteration – Restriction
| 14147N | IVACAFTOR, ivacaftor 25 mg granules, 56 sachets (Kalydeco) |
| 14165M | IVACAFTOR, ivacaftor 25 mg granules, 56 sachets (Kalydeco) |
| 11097C | IVACAFTOR, ivacaftor 50 mg granules, 56 sachets (Kalydeco) |
| 14158E | IVACAFTOR, ivacaftor 50 mg granules, 56 sachets (Kalydeco) |
| 11109Q | IVACAFTOR, ivacaftor 75 mg granules, 56 sachets (Kalydeco) |
| 14157D | IVACAFTOR, ivacaftor 75 mg granules, 56 sachets (Kalydeco) |
| 10175M | IVACAFTOR, ivacaftor 150 mg tablet, 56 (Kalydeco) |
| 14169R | IVACAFTOR, ivacaftor 150 mg tablet, 56 (Kalydeco) |
| 10956P | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair) |
| 10968G | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11175E | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11953D | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11164N | USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma) |
| 13255P | USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma) |
| 13804M | USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma) |
Alteration – Restriction Level
| From | To | ||
| 11953D | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) | authority-required | streamlined |
Advance Notices
1 September 2025
Deletion – Brand
| 6209T | MycoCept, RF – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
| 6280M | Valaciclovir APOTEX, GX – VALACICLOVIR, valaciclovir 500 mg tablet, 100 |
Highly Specialised Drugs Program (Public Hospital)
Additions
Addition – Item
| 14880E | EFLORNITHINE, eflornithine 192 mg tablet, 100 (Ifinwil) |
| 14894X | EFLORNITHINE, eflornithine 192 mg tablet, 100 (Ifinwil) |
| 14914Y | FOSLEVODOPA + FOSCARBIDOPA, foslevodopa 2.4 g/10 mL + foscarbidopa 120 mg/10 mL injection, 7 x 10 mL vials (Vyalev) |
| 14924L | FOSLEVODOPA + FOSCARBIDOPA, foslevodopa 2.4 g/10 mL + foscarbidopa 120 mg/10 mL injection, 7 x 10 mL vials (Vyalev) |
| 14905L | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair) |
| 14920G | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo) |
| 14947Q | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo) |
| 14949T | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair) |
| 14950W | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL pen device (Xolair) |
| 14884J | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair) |
| 14922J | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair) |
| 14929R | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair) |
| 14937E | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair) |
| 14945N | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL pen device (Xolair) |
| 14946P | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 14948R | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 14885K | OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair) |
| 14895Y | OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair) |
| 14906M | OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair) |
| 14913X | OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair) |
| 14952Y | OMALIZUMAB, omalizumab 300 mg/2 mL injection, 2 mL pen device (Xolair) |
Note - Erratum
The listing of ivacaftor item codes 14881F and 14901G is no longer proceeding for
1 August 2025.
Addition – Brand
| 10118M | Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 10967F | Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 11835X | Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 11846L | Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 11946R | Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 11962N | Omlyclo, EW – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 10109C | Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 10973M | Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11168T | Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11176F | Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11824H | Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11828M | Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11945Q | Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11950Y | Omlyclo, EW – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11182M | Steqeyma, EW – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial |
| 13272M | Steqeyma, EW – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial |
| 13781H | Steqeyma, EW – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial |
Addition – Equivalence Indicator
| 10118M | Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 10967F | Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 11835X | Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 11846L | Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 11946R | Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 11962N | Xolair, NV – OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe |
| 11182M | Stelara, JC – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial |
| 13272M | Stelara, JC – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial |
| 13781H | Stelara, JC – USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial |
Addition – Note
| 10118M | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair) |
| 10967F | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair) |
| 11835X | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair) |
| 11846L | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair) |
| 10109C | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11824H | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11828M | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
Addition – Caution
| 10967F | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair) |
| 11946R | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair) |
| 11962N | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair) |
| 10973M | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11945Q | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11950Y | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
Deletions
Deletion – Brand
| 10109C | Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 10973M | Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11168T | Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11176F | Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11824H | Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11828M | Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11945Q | Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
| 11950Y | Xolair, NV – OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe |
Alterations
Alteration – Item Description
| From | |
| 14785E | MACITENTAN + TADALAFIL, macitentan 10 mg + tadalafil 40 mg tablet, 30 (Opsynvi) |
| To | |
| 14785E | MACITENTAN + TADALAFIL, Macitentan 10 mg + tadalafil 40 mg tablet, 30 (Opsynvi) |
| From | |
| 14810L | VUTRISIRAN, vutrisiran 25 mg/0.5 mL injection, 0.5 mL syringe (Amvuttra) |
| To | |
| 14810L | VUTRISIRAN, Vutrisiran 25 mg/0.5 mL injection, 0.5 mL syringe (Amvuttra) |
Alteration – Note
| 11168T | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11176F | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11945Q | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11182M | USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma) |
| 13272M | USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma) |
| 13781H | USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma) |
Alteration – Restriction
| 14155B | IVACAFTOR, ivacaftor 25 mg granules, 56 sachets (Kalydeco) |
| 14156C | IVACAFTOR, ivacaftor 25 mg granules, 56 sachets (Kalydeco) |
| 11105L | IVACAFTOR, ivacaftor 50 mg granules, 56 sachets (Kalydeco) |
| 14148P | IVACAFTOR, ivacaftor 50 mg granules, 56 sachets (Kalydeco) |
| 11098D | IVACAFTOR, ivacaftor 75 mg granules, 56 sachets (Kalydeco) |
| 14167P | IVACAFTOR, ivacaftor 75 mg granules, 56 sachets (Kalydeco) |
| 10170G | IVACAFTOR, ivacaftor 150 mg tablet, 56 (Kalydeco) |
| 14153X | IVACAFTOR, ivacaftor 150 mg tablet, 56 (Kalydeco) |
| 10967F | OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Omlyclo, Xolair) |
| 10973M | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11176F | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11945Q | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) |
| 11182M | USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma) |
| 13272M | USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma) |
| 13781H | USTEKINUMAB, ustekinumab 130 mg/26 mL injection, 26 mL vial (Stelara, Steqeyma) |
Alteration – Restriction Level
| From | To | ||
| 11945Q | OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Omlyclo) | authority-required | streamlined |
Advance Notices
1 September 2025
Deletion – Brand
| 9502D | MycoCept, RF – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
| 9568N | Valaciclovir APOTEX, GX – VALACICLOVIR, valaciclovir 500 mg tablet, 100 |
Highly Specialised Drugs Program (Community Access)
Deletions
Deletion – Item
| 14637J | TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 (Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg/300 mg Tablets (Laurus Labs, USA)) |
Deletion – Brand
| 10310P | Tenofovir APOTEX, TX – TENOFOVIR DISOPROXIL, tenofovir disoproxil fumarate 300 mg tablet, 30 |
| 11992E | Tenofovir APOTEX, TX – TENOFOVIR DISOPROXIL, tenofovir disoproxil fumarate 300 mg tablet, 30 |
Deletion – Note
| 10347N | TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 (CIPLA TENOFOVIR + EMTRICITABINE 300/200, TENOFOVIR/EMTRICITABINE 300/200 APX, TENOFOVIR/EMTRICITABINE 300/200 ARX) |
| 11149T | TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil maleate 300 mg + emtricitabine 200 mg tablet, 30 (Tenofovir Disoproxil Emtricitabine Viatris 300/200) |
| 12506F | TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil succinate 301 mg + emtricitabine 200 mg tablet, 30 (Tenofovir/Emtricitabine Sandoz 301/200) |
Advance Notices
1 October 2025
Deletion – Brand
| 10348P | Lamivudine Alphapharm, AF – LAMIVUDINE, lamivudine 150 mg tablet, 60 |
| 10310P | Viread, GI – TENOFOVIR DISOPROXIL, tenofovir disoproxil fumarate 300 mg tablet, 30 |
| 11992E | Viread, GI – TENOFOVIR DISOPROXIL, tenofovir disoproxil fumarate 300 mg tablet, 30 |
Repatriation Pharmaceutical Benefits
Additions
Addition – Brand
| 4115N | Azithromycin-WGR, WG – AZITHROMYCIN, azithromycin 500 mg tablet, 3 |
| 4592Q | GABAPENTIN-WGR, WG – GABAPENTIN, gabapentin 300 mg capsule, 100 |
| 4593R | GABAPENTIN-WGR, WG – GABAPENTIN, gabapentin 400 mg capsule, 100 |
| 4594T | APX-GABAPENTIN, TX – GABAPENTIN, gabapentin 600 mg tablet, 100 |
| 4350Y | MUPIROCIN-WGR, WG – MUPIROCIN, mupirocin 2% ointment, 15 g |
| 10598T | APOHEALTH Osteo Relief Paracetamol 665 mg, TX – PARACETAMOL, paracetamol 665 mg modified release tablet, 96 |
| 14197F | RISEDRONATE-WGR, WG – RISEDRONATE, risedronate sodium 35 mg tablet, 4 |
| 4444X | RISEDRONATE-WGR, WG – RISEDRONATE, risedronate sodium 35 mg tablet, 4 |
| 4596X | TADALAFIL-WGR, WG – TADALAFIL, tadalafil 10 mg tablet, 4 |
| 4597Y | TADALAFIL-WGR, WG – TADALAFIL, tadalafil 20 mg tablet, 4 |
| 14200J | TAMSULOSIN-WGR SR, WG – TAMSULOSIN, tamsulosin hydrochloride 400 microgram modified release tablet, 30 |
| 4070F | TAMSULOSIN-WGR SR, WG – TAMSULOSIN, tamsulosin hydrochloride 400 microgram modified release tablet, 30 |
| 4011D | TERBINAFINE-WGR, WG – TERBINAFINE, terbinafine 250 mg tablet, 42 |
| 13307J | APO-Zopiclone, TX – ZOPICLONE, zopiclone 7.5 mg tablet, 14 |
| 13307J | Imoclone, RW – ZOPICLONE, zopiclone 7.5 mg tablet, 14 |
Addition – Equivalence Indicator
| 13307J | Imovane, SW – ZOPICLONE, zopiclone 7.5 mg tablet, 14 |
Deletions
Deletion – Item
| 4468E | CROMOGLYCATE, sodium cromoglycate 2% nasal spray, 26 mL (Rynacrom) |
Advance Notices
1 September 2025
Deletion – Brand
| 14200J | Blooms the Chemist Tamsulosin SR, IB – TAMSULOSIN, tamsulosin hydrochloride 400 microgram modified release tablet, 30 |
| 4070F | Blooms the Chemist Tamsulosin SR, IB – TAMSULOSIN, tamsulosin hydrochloride 400 microgram modified release tablet, 30 |
Efficient Funding of Chemotherapy (Private Hospital)
Additions
Addition – Item
| 14889P |
DURVALUMAB, durvalumab 120 mg/2.4 mL injection, 2.4 mL vial (Imfinzi); durvalumab 500 mg/10 mL injection, 10 mL vial (Imfinzi) |
| 14932X |
DURVALUMAB, durvalumab 120 mg/2.4 mL injection, 2.4 mL vial (Imfinzi); durvalumab 500 mg/10 mL injection, 10 mL vial (Imfinzi) |
Deletions
Deletion – Brand
| 10699D | Arsenic Trioxide-AFT, AE – ARSENIC, arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules |
| 7241D | Arsenic Trioxide-AFT, AE – ARSENIC, arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules |
| 12219D | Bortezomib Sandoz, SZ – BORTEZOMIB, bortezomib 3.5 mg injection, 1 vial |
| 7234R | Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 1 g/20 mL injection, 20 mL vial |
| 7239B | Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 1 g/20 mL injection, 20 mL vial |
| 7234R | Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 5 g/100 mL injection, 100 mL vial |
| 7239B | Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 5 g/100 mL injection, 100 mL vial |
Deletion – Note
| 11906P | NIVOLUMAB, nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo); nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo) |
Note - Erratum
The administrative note ‘Special Pricing Arrangements apply.’ for durvalumab item codes 11911X, 13745K, 13766M and 13779F was inadvertently removed, the Special Pricing Arrangement note is intended to apply in August as shown in the erratum.
Alterations
Alteration – Restriction
| 2638W |
IPILIMUMAB, ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy); ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy) |
| 10775D |
NIVOLUMAB, nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo); nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo) |
| 11906P |
NIVOLUMAB, nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo); nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo) |
| 14664T |
NIVOLUMAB + RELATLIMAB, nivolumab 240 mg/20 mL + relatlimab 80 mg/20 mL injection, 20 mL vial (Opdualag) |
| 10475H |
PEMBROLIZUMAB, pembrolizumab 100 mg/4 mL injection, 4 mL vial (Keytruda) |
| 12122B |
PEMBROLIZUMAB, pembrolizumab 100 mg/4 mL injection, 4 mL vial (Keytruda) |
Advance Notices
1 September 2025
Deletion – Brand
| 7255W | Pemetrexed APOTEX, TX – PEMETREXED, pemetrexed 500 mg injection, 1 vial |
| 7263G | Navelbine, FB – VINORELBINE, vinorelbine 50 mg/5 mL injection, 5 mL vial |
Efficient Funding of Chemotherapy (Public Hospital)
Additions
Addition – Item
| 14925M |
DURVALUMAB, durvalumab 120 mg/2.4 mL injection, 2.4 mL vial (Imfinzi); durvalumab 500 mg/10 mL injection, 10 mL vial (Imfinzi) |
| 14942K |
DURVALUMAB, durvalumab 120 mg/2.4 mL injection, 2.4 mL vial (Imfinzi); durvalumab 500 mg/10 mL injection, 10 mL vial (Imfinzi) |
Deletions
Deletion – Brand
| 10691Q | Arsenic Trioxide-AFT, AE – ARSENIC, arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules |
| 4371C | Arsenic Trioxide-AFT, AE – ARSENIC, arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules |
| 12227M | Bortezomib Sandoz, SZ – BORTEZOMIB, bortezomib 3.5 mg injection, 1 vial |
| 4394G | Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 1 g/20 mL injection, 20 mL vial |
| 4431F | Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 1 g/20 mL injection, 20 mL vial |
| 4394G | Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 5 g/100 mL injection, 100 mL vial |
| 4431F | Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 5 g/100 mL injection, 100 mL vial |
Deletion – Note
| 11900H | NIVOLUMAB, nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo); nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo) |
Note - Erratum
The administrative note ‘Special Pricing Arrangements apply.’ for durvalumab item codes 11915D, 13767N, 13775B and 13780G was inadvertently removed, the Special Pricing Arrangement note is intended to apply in August as shown in the erratum.
Alterations
Alteration – Restriction
| 2641B |
IPILIMUMAB, ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy); ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy) |
| 10764M |
NIVOLUMAB, nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo); nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo) |
| 11900H |
NIVOLUMAB, nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo); nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo) |
| 14678M |
NIVOLUMAB + RELATLIMAB, nivolumab 240 mg/20 mL + relatlimab 80 mg/20 mL injection, 20 mL vial (Opdualag) |
| 10493G |
PEMBROLIZUMAB, pembrolizumab 100 mg/4 mL injection, 4 mL vial (Keytruda) |
| 12128H |
PEMBROLIZUMAB, pembrolizumab 100 mg/4 mL injection, 4 mL vial (Keytruda) |
Advance Notices
1 September 2025
Deletion – Brand
| 4600D | Pemetrexed APOTEX, TX – PEMETREXED, pemetrexed 500 mg injection, 1 vial |
| 4620E | Navelbine, FB – VINORELBINE, vinorelbine 50 mg/5 mL injection, 5 mL vial |
Related Pharmaceutical Benefits for Public Hospital use
Deletions
Deletion – Brand
| 5899L | Granisetron-AFT, AE – GRANISETRON, granisetron 3 mg/3 mL injection, 3 mL ampoule |
Deletion – Equivalence Indicator
| 5899L | Kytril, IX – GRANISETRON, granisetron 3 mg/3 mL injection, 3 mL ampoule |
Alterations
Alteration – Item Description
| From | |
| 14803D | EPCORITAMAB, epcoritamab 4 mg/0.8 mL injection, 0.8 mL vial (Epkinly) |
| To | |
| 14803D | EPCORITAMAB, Epcoritamab 4 mg/0.8 mL injection, 0.8 mL vial (Epkinly) |
| From | |
| 14826H | EPCORITAMAB, epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly) |
| To | |
| 14826H | EPCORITAMAB, Epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly) |
| From | |
| 14827J | EPCORITAMAB, epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly) |
| To | |
| 14827J | EPCORITAMAB, Epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly) |
Advance Notices
1 September 2025
Deletion – Brand
| 5967C | APO-Ondansetron, TX – ONDANSETRON, ondansetron 4 mg tablet, 4 |
| 5968D | APO-Ondansetron, TX – ONDANSETRON, ondansetron 8 mg tablet, 4 |
1 October 2025
Deletion – Brand
| 5857G | Ondansetron Mylan ODT, AF – ONDANSETRON, ondansetron 4 mg orally disintegrating tablet, 4 |
